Search for: "Apotex Inc."
Results 581 - 600
of 671
Sort by Relevance
|
Sort by Date
14 Apr 2008, 11:51 am
Circuit Court of Appeals, April 07, 2008 Nufarm America's, Inc. v. [read post]
10 Apr 2008, 9:45 am
Apotex Inc., ___ F.3d ___, 2008 WL 927848 (3d Cir. [read post]
9 Apr 2008, 2:00 pm
APOTEX INC. [read post]
9 Apr 2008, 5:39 am
Apotex Inc.. [read post]
6 Apr 2008, 11:01 pm
Apotex (on norvasc), discussed in Obviousness: knowing it when you see it? [read post]
14 Mar 2008, 6:07 am
Depuy Orthopaedics, Inc., 295 F. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
3 Mar 2008, 9:27 pm
Apotex, Inc. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
23 Feb 2008, 4:24 am
Teleflex, Inc., 126 S. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
17 Feb 2008, 9:16 pm
Apotex Inc. et al. 1:08-cv-00827; filed February 7, 2008 in the Northern District of... [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
12 Feb 2008, 1:30 pm
Attorney General (Canada) noting also that, according to Apotex Fermentation Inc. v. [read post]
8 Feb 2008, 8:52 pm
Nu-Pharm, a former subsidiary of Apotex, has appealed the decision to the D.C. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
3 Feb 2008, 9:47 pm
Apotex Inc. v. [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the generic… [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
17 Jan 2008, 7:55 am
Liggett Group, Inc., 505 U.S. 504 (1992) (holding that state common law torts were something that was subject to preemption), Medtronic, Inc. v. [read post]
